NICE to meet with venture capitalists?: Source: Kantar Media Intelligence Health News
According to an article in the Financial Times, NICE is to begin talks with venture capitalists to discuss which experimental treatments would be most likely to be purchased by the NHS. It states that this approach could strengthen the UK's life sciences sector by helping funders direct money into those experimental treatments that are more likely to be determined as cost effective.
Professor Carole Longson, director of NICE's health technology evaluation centre, told the Financial Times: "We are exploring the possibility of providing advice to the investment community. Our focus lies in providing clarity about the data that [need] to be generated in order to demonstrate the value of products to the healthcare system." NeLM - News
No comments:
Post a Comment